Hemolytic Reactions | Reaction | Response | Treatment |
Acute Hemolytic Transfusion Reaction | Antibody reaction + Complement fixation to rbc A, B, Kell, Kidd, Duffy and Ss antigens | Hemolysis, acute renal failure, hypotension, bronchospasm, DIC | Supportive measures: inotropes and vasopressors to prevent shock, maintain intravascular volume and urine output with IVF and diuretics |
Delayed Hemolytic Reactions
| Prior sensitization to donor antigens (kidd, kell, Rh) – low levels of antibodies over time such that they are not detected on routine screening. Transfusion exposure causes an anamnestic response. | Usually rbc destruction occurs extravascularly and symptoms are less severe than AHTR. Low grade fever, ↑ indirect bilirubin, jaundice, anemia | Supportive, hydration and transfusion of compatible rbc as necessary
|
Nonhemolytic reactions |
|
|
|
Minor Allergic Reactions | Allergic reaction to donor plasma proteins | Rash, pruritus, swelling | Diphenhydramine, Steroids |
Anaphylactic Reactions | Prior sensitization in a patient with IgA deficiency and subsequent exposure to IgA containing product | Dyspnea, bronchospasm, angioedema, hypotension | Steroids, epinephrine |
Febrile reactions | Antibody reactions to donor leukocytes. | Typically >1◦C rise in temperature within 4 hours of transfusion plus chills, myalgia, nausea, non-productive cough, respiratory distress | Acetaminophen. Usually defervesce in 48 hours.
|
Transfusion-Related Acute Lung Injury (TRALI)
| Anti- HLA antibodies in the donor interacts with recipients leukocytes causing aggregation in the pulmonary circulation | Fever, chills, non-cardiogenic pulmonary edema, bilateral pulmonary infiltrates and severe pulmonary insufficiency | Supportive. Usually resolves in 24-48 hours with supportive care |
Graft-Versus-Host Disease (GVHD) | Donor lymphocytes may not be rejected in immunosuppressed patients. They can proliferate and establish an immune response against the recipient. Typically with transfusion of cellular products, less with FFP and cryoprecipitate. | Rapid pancytopenia | Irradiation of blood products is the only proven preventive measure. |
Clinical experience with power injectable peripherally inserted central catheters in intensive care patients Introduction In intensive care units (ICU), peripherally inserted central catheters (PICC) may be an alternative option to standard central venous catheters, particularly in patients with coagulation disorders or at high risk for infection. Some limits of PICCs (such as low flow rates) may be overcome by the use of power-injectable catheters . Method We have retrospectively reviewed all the power injectable PICCs inserted in adult and pediatric patients in the ICU during a 12-month period, focusing on the rate of complications at insertion and during maintenance. Results We have collected 89 power injectable PICCs (in adults and in children), both multiple and single lumen. All insertions were successful. There were no major complications at insertion and no episodes of catheter-related blood stream infection. Non-infective complications ...
Woww your blog. Very informative and useful.
ReplyDeletePediatric Adult Resectoscopes and Sheaths